New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
08:59 EDTCVM, ICPT, MDT, C, NBG, ACOR, EW, YHOO, AKBA, WBMD, LXRX, FBOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Citigroup (C), up 3.7%. ALSO HIGHER: Yahoo (YHOO), up 1.7% after upgraded to Buy from Neutral at SunTrust... Facebook (FB), up 2.5% after Financial Times reports company looking to provide financial services... Lexicon (LXRX), up 19.5% after achieving positive results in Type 1 diabetes clinical trial... Akebia (AKBA), up 13.8% after initiated at Nomura, Credit Suisse, Morgan Stanley and UBS... WebMD (WBMD), up 10% after saying it now sees Q1 adjusted EBITDA to come in above the high end of its previous guidance... Intercept (ICPT), up 4.9% after reporting additional data from POISE trial at EASL... Ewards Lifesciences (EW), up 11.3% after a district court granted a preliminary injunction limiting the sale of Medtronic's (MDT) CoreValve system in the U.S. Medtronic shares down 5.2% following the news. ALSO LOWER: National Bank of Greece (NBG), down 10.7% after Reuters says bank selected Goldman Sachs (GS) and Morgan Stanley (MS) as global coordinators for a planned equity offering... : CEL-SCI (CVM), down 10.6% after announcing intent to offer common stock, six month warrants in 'best efforts' offering... Acorda Therapeutics (ACOR), down 6.2% after pushing off start of Phase 3 study of dalfampridine-QD to second half of year.
News For YHOO;C;FB;EW;MDT;LXRX;ACOR;ICPT;WBMD;NBG;CVM;AKBA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
November 17, 2014
06:16 EDTYHOOInvestors wanting Alibaba should consider Yahoo, says Citigroup
Subscribe for More Information
November 16, 2014
14:08 EDTMDTDaVita announces collaboration with Medtronic
DaVita Kidney Care, a division of DaVita HealthCare Partners (DVA) and leading provider of kidney care services, announced a collaboration with Medtronic (MDT) to better understand cardiovascular health in end stage renal disease, ESRD patients. The collaboration will focus on developing a pilot program using Medtronic's Reveal LINQ Insertable Cardiac Monitoring system to identify cardiac arrhythmias in patients receiving dialysis. "Medtronic recently announced data at the American Society of Nephrology meeting that showed a higher incidence of arrhythmias in patients receiving hemodialysis," said Ven Manda, vice president, Renal Care Solutions at Medtronic. "We are pleased to pursue this collaboration with DaVita to monitor more patients and gather additional data that will further our understanding of the relationship between dialysis and cardiac events in ESRD patients." "Given the high incidence rate of cardiovascular disease and events in ESRD patients, we believe that by collaborating with Medtronic, we can gain knowledge to help improve the lives of ESRD patients," said Mahesh Krishnan, vice president for clinical innovation and public policy for DaVita HealthCare Partners. "Through the collaboration we expect to utilize innovative monitoring technology and data from our DaVita Kidney Care information systems across the country. This effort is poised to improve the lives of patients by proactively detecting and preventing cardiac complications."
November 14, 2014
17:07 EDTFB, YHOOSoros Fund Management gives quarterly update on stakes
Subscribe for More Information
16:01 EDTFBOptions Update; November 14, 2014
Subscribe for More Information
15:22 EDTICPTIntercept CEO says company 'very well-positioned' in terms of balance sheet
Subscribe for More Information
13:03 EDTYHOOYahoo rises after analysts boost targets
Subscribe for More Information
12:43 EDTMDTMedtronic readying $10B bond sale for Covidien deal, WSJ reports
Subscribe for More Information
11:50 EDTMDTMedtronic readying $10B bond sale for Covidien deal, Dow reports
Subscribe for More Information
08:25 EDTYHOOYahoo price target raised to $61 from $49 at Oppenheimer
Oppenheimer increased its price target on Yahoo (YHOO) as the firm raised its valuation of Alibaba (BABA) to $324B from $275B. The firm keeps an Outperform rating on Yahoo.
08:21 EDTYHOOYahoo price target raised to $60 from $50 at FBR Capital
FBR Capital raised its price target for Yahoo (YHOO) shares to $60 to reflect Alibaba (BABA) stock appreciation. FBR says Yahoo offers a lower-cost play on Alibaba with the potential for improved core Yahoo performance. It keeps an Outperform rating on the stock.
07:32 EDTFBHayman Capital gives quarterly update on stakes
Subscribe for More Information
06:24 EDTFBFacebook implied volatility of 27 at lower end of index mean range
November 13, 2014
16:35 EDTMDTMedtronic study reveals heart rhythm disorders in patients with ESRD
Subscribe for More Information
16:03 EDTFBOptions Update; November 13, 2014
Subscribe for More Information
14:50 EDTMDTLonestar Capital to shut down by mid-2015, WSJ reports
Subscribe for More Information
14:45 EDTMDTLonestar capital to shut down, DJ reports
Subscribe for More Information
13:27 EDTMDTMedtronic likely to continue to make new highs, Barron's says
Subscribe for More Information
11:22 EDTFBDan Niles says looking to short more of Twitter
Subscribe for More Information
10:05 EDTFBFacebook quietly launches Yelp rival, TNW reports
Subscribe for More Information
07:38 EDTYHOO, FBBloomberg Link to hold a conference
The Year Ahead: 2015 is being held in Washington, D.C. with a pre-conference dinner on November 13 followed by company presentations on November 14,
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use